M. Laird Forrest

Prof. M. Laird Forrest

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 December 2011 in Chemical Society Reviews
Verified
Journal Article
Closed access
PDF file
Shahriar SharifiShahriar Sharifi
Shahriar Sharifi
SBShahed Behzadi
Shahed Behzadi
SLSophie Laurent
Sophie Laurent
MFM. Laird Forrest
M. Laird Forrest
PSPieter Stroeve
Pieter Stroeve
Morteza MahmoudiMorteza Mahmoudi
Morteza Mahmoudi
Nanoscience has matured significantly during the last decade as it has transitioned from bench top science to applied technology. Presently, nanomaterials are used in a wide variety of commercial products such as electronic components, sports equipment, sun creams and biomedical applications. There are few studies of the long-term consequences of nanoparticles on human health, but governmental agencies, including the United States National Institute for Occupational Safety and Health and Japan's Ministry of Health, have recently raised the question of whether seemingly innocuous materials such as carbon-based nanotubes should be treated with the same caution afforded known carcinogens such as asbestos. Since nanomaterials are increasing a part of everyday consumer products, manufacturing processes, and medical products, it is imperative that both workers and end-users be protected from inhalation of potentially toxic NPs. It also suggests that NPs may need to be sequestered into products so that the NPs are not released into the atmosphere during the product's life or during recycling. Further, non-inhalation routes of NP absorption, including dermal and medical injectables, must be studied in order to understand possible toxic effects. Fewer studies to date have addressed whether the body can eventually eliminate nanomaterials to prevent particle build-up in tissues or organs. This critical review discusses the biophysicochemical properties of various nanomaterials with emphasis on currently available toxicology data and methodologies for evaluating nanoparticle toxicity (286 references).

1 June 2009 in Advanced Drug Delivery Reviews
Verified
Journal Article
Open access
KAKristin L. Aillon
Kristin L. Aillon
YXYumei Xie
Yumei Xie
NENashwa El-Gendy
Nashwa El-Gendy
CBCory J. Berkland
Cory J. Berkland
MFM. Laird Forrest
M. Laird Forrest
It is well recognized that physical and chemical properties of materials can alter dramatically at nanoscopic scale, and the growing use of nanotechnologies requires careful assessment of unexpected toxicities and biological interactions. However, most in vivo toxicity concerns focus primarily on pulmonary, oral, and dermal exposures to ultrafine particles. As nanomaterials expand as therapeutics and as diagnostic tools, parenteral administration of engineered nanomaterials should also be recognized as a critical aspect for toxicity consideration. Due to the complex nature of nanomaterials, conflicting studies have led to different views of their safety. Here, the physicochemical properties of four representative nanomaterials (dendrimers, carbon nanotubes, quantum dots, and gold nanoparticles) as it relates to their toxicity after systemic exposure is discussed.

27 August 2009 in Expert Opinion on Drug Delivery
Verified
Journal Article
Closed access
SNSatish K Nune
Satish K Nune
PGPadmaja Gunda
Padmaja Gunda
PTPraveen Thallapally
Praveen Thallapally
YLYing-Ying Lin
Ying-Ying Lin
MFM. Laird Forrest
M. Laird Forrest
CBCory J Berkland
Cory J Berkland
Background: Synthetic nanoparticles are emerging as versatile tools in biomedical applications, particularly in the area of biomedical imaging. Nanoparticles 1 – 100 nm in diameter have dimensions ...

26 August 2003 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
MFM. Laird Forrest
M. Laird Forrest
JKJames T. Koerber
James T. Koerber
DPDaniel W. Pack
Daniel W. Pack

1 May 2008 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
KVKarina R. Vega-Villa
Karina R. Vega-Villa
JTJody K. Takemoto
Jody K. Takemoto
JYJaime A. Yáñez
Jaime A. Yáñez
CRConnie Remsberg
Connie Remsberg
MFM. Laird Forrest
M. Laird Forrest
NDNeal M. Davies
Neal M. Davies

16 May 2011 in Therapeutic Delivery
Verified
Journal Article
Closed access
JYJaime A Yáñez
Jaime A Yáñez
CRConnie Remsberg
Connie Remsberg
CSCasey Sayre
Casey Sayre
MFM. Laird Forrest
M. Laird Forrest
NDNeal Davies
Neal Davies
Flip-flop pharmacokinetics is a phenomenon often encountered with extravascularly administered drugs. Occurrence of flip-flop spans preclinical to human studies. The purpose of this article is to a...